Safety of egg membrane collagen peptides as a novel food pursuant to Regulation (EU) 2015/2283
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on egg membrane collagen peptides as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is derived from farmed chicken eggs. It is produced...
| Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2025 |
| Country: | España |
| Institution: | Universidad de Sevilla (US) |
| Repository: | idUS. Depósito de Investigación de la Universidad de Sevilla |
| OAI Identifier: | oai:idus.us.es:11441/182637 |
| Online Access: | https://hdl.handle.net/11441/182637 https://doi.org/10.2903/j.efsa.2025.9709 |
| Access Level: | Open access |
| Keyword: | Collagen Egg membrane Food supplement Novel foods Safety |
| Summary: | Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on egg membrane collagen peptides as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is derived from farmed chicken eggs. It is produced by enzymatic hydrolysis, and it contains 15%–30% collagen peptides. The production process is sufficiently described and does not raise safety concerns. The applicant proposed to market the NF for use in food supplements for adults, excluding pregnant and lactating women, at a maximum daily dose of 500 mg. Taking into account the nature of the NF, the compositional data and information on the production process, the Panel considers that no toxicological studies are required for the NF. The Panel concludes that the NF, egg membrane collagen peptides, is safe under the proposed conditions of use. |
|---|